RxDoctor Payments Data

Wei Zhang

Clinical Pathology/Laboratory Medicine · Kansas City, KSNPI 1669813242

Payments from drug & device makers

$22,272in general payments, 2019–2025

Across 38 payments — averaging $586.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Jazz Pharmaceuticals Inc.$16K
  • Gilead$3K
  • Eli Lilly$1K
  • Incyte Corporation$1K
  • Illumina, Inc.$201
  • Syndax Pharmaceuticals, Inc.$125
  • plus $545 from 7 others

What the payments were for

  • Consulting fees$19,63588%
  • Travel & lodging$1,4777%
  • Food & beverage$1,1605%

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Jazz Pharmaceuticals Inc.13$16,131
Gilead8$2,505
Eli Lilly1$1,400
Incyte Corporation1$1,365
Illumina, Inc.3$201
Syndax Pharmaceuticals, Inc.1$125
AstraZeneca1$125
Regeneron Healthcare Solutions, Inc.1$122
Labcorp Holdings Inc.1$113
TG Therapeutics, Inc.5$109
Lilly USA, LLC1$30
Abbott1$27
Pfizer1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few clinical pathology/laboratory medicine providers in Kansasto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$61,681
Medicare patients
720
Services billed
1,682

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other clinical pathology/laboratory medicine in Kansas City

Where these figures come from

Is this you, or does something look wrong? →